Intracellular protein trafficking is tightly regulated, and improper trafficking might be the fundamental provocateur for human diseases including neurodegeneration. In neurons, protein trafficking to and from the plasma membrane affects synaptic plasticity. Voltage-gated potassium channel 2.1 (Kv2.1) is a predominant delayed rectifier potassium (K + ) current, and electrical activity patterns of dopamine (DA) neurons within the substantia nigra are generated and modulated by the orchestrated function of different ion channels. The pathological hallmark of Parkinson's disease (PD) is the progressive loss of these DA neurons, resulting in the degeneration of striatal dopaminergic terminals. However, whether trafficking of Kv2.1 channels contributes to PD remains unclear. In this study, we demonstrated that MPTP/ MPP + increases the surface expression of the Kv2.1 channel and causes nigrostriatal degeneration by using a subchronic MPTP mouse model. The inhibition of the Kv2.1 channel by using a specific blocker, guangxitoxin-1E, protected nigrostriatal projections against MPTP/MPP + insult and thus facilitated the recovery of motor coordination. These findings highlight the importance of trafficking of Kv2.1 channels in the pathogenesis of PD.
Parkinson's disease (PD), a movement disorder caused by the loss of DA neurons in the substantia nigra (SN) and the degeneration of DA terminals in the dorsal striatum (STR), has been considered a mitochondrial dysfunction-related disease (Henchcliffe and Beal 2008; Schapira 2008; Vila et al. 2008) . MPTP/MPP + inhibits mitochondrial complex I, reduces ATP production, and produces parkinsonism (Betarbet et al. 2000; Przedborski et al. 2004) . Moreover, advances in genetic and experimental PD model systems have highlighted a crucial role of defects in intracellular trafficking (Abeliovich and Gitler 2016) . The unique architecture of midbrain DA neurons can harbor the exuberance and vast number of their axons and synaptic terminals, which pose a particular challenge for protein trafficking. Defective trafficking is the most prominent mechanism in many human diseases Hannan 2000, 2002; Chen et al. 2005; Maattanen et al. 2010) .
Voltage-gated potassium channel 2.1 (Kv2.1) is abundantly expressed in mammalian brain neurons and is specifically localized in the somata and proximal dendrites (Trimmer 1991; Lim et al. 2000) as well as in the axon initial segment (Sarmiere et al. 2008 ). The Kv2.1 channel mediates the majority of the delayed rectifier K + current (I kDR ) in neurons, and cells exogenously expressing the Kv2.1 channel are substantially more sensitive to apoptosis (Pal et al. 2003) . To enable apoptosis, the cellular loss of K + was facilitated by inserting Kv2.1 channels into the plasma membrane, followed by enabling protease and nuclease activation during apoptosis (McCord and Aizenman 2013) .
In this study, we demonstrated that MPTP treatment increases the surface expression and alters the distribution of the Kv2.1 channel to cause loss of DA neurons in the SN and DA terminals in the STR by using the subchronic MPTP mouse model. The inhibition of Kv2.1 channels by using guangxitoxin-1E (GxTx) protected the nigrostriatal DA pathway against MPTP and facilitated the recovery of motor coordination. Our findings suggest that MPTP/MPP + regulates trafficking and surface abundance of Kv2.1 channels to initiate DA neuronal death.
Materials and methods
Chemicals and antibodies MPTP (Cat# M0896), tetraethylammonium (TEA) (Cat# T2265), and MPP + (Cat# D048) were purchased from Sigma-Aldrich (St. Louis, MO, USA). GxTx (Cat# 4433-s) was purchased from Peptide Institute (Osaka, Japan). The Kv2.1 antibody was purchased from NeuroMab (UC Davis/NIH NeuroMab Facility, Cat# 75-014, RRID: AB_10673392, Davis, CA, USA). The G-protein-coupled inwardly rectifying potassium channels 1 (GIRK1) (Cat# AB5198, RRID: AB_91745), pAMPK (Cat# 07-363, RRID:AB_310553), cleaved caspase 3 (Cat# AB3623 RRID:AB_91556), and TH (Cat# AB152, RRID:AB_390204) antibodies was purchased from EMD Millipore (Billerica, MA, USA), and the actin antibody (Cat# A1978, RRID: AB_476692) was purchased from Sigma-Aldrich. Alexa Fluorconjugated secondary antibodies (Cat# PA5-23091, RRID: AB_2540618) were purchased from Thermo Fisher Scientific (Hudson, NH, USA). Donkey anti-rabbit IgG Horseradish peroxidase-conjugated (Cat# NA9340-1 mL, RRID:AB_772191) and sheep anti-mouse IgG Horseradish peroxidase-conjugated (Cat# NA9310-1 mL, RRID:AB_772193) secondary antibodies were purchased from GE Healthcare Life Sciences (Pittsburgh, PA, USA).
Animal environment C57BL/6N mice were imported from Jackson Laboratories (Bar Harbor, ME, USA, RRID:IMSR_JAX:005304) and continuously maintained in the animal center of National Cheng Kung University (NCKU). Male mice weighing 18-20 g were housed 5 per cage under a 12-h light/12-h dark cycle (lights on at 8 am and lights off at 8 pm). The constant temperature (25°C) and humidity in the control room was under the supervision of qualified caretakers in the NCKU Animal Core for at least 1 week before experiments. The mice were allowed free access to food and water. All experimental procedures were performed during the light cycle. The ethical guidelines provided by the NCKU Animal Care and Use Committee (ethical approval reference number: 105191) were followed throughout the study. Guidelines were set to minimize animals' suffering by improving the experimental design and statistical analysis used in the study or by improving experimental procedures. If animals indicate a change in appetite, activity, or an open wound during experiments, animals were given oral or injectable analgesics such as Aspirin. All animal work was done in consultation with a veterinarian. We used the variable -criteria Sequential-Stopping Rules -in combination with a t-test and one-way ANOVA to determine the sample size. Setting a power of 80% (type I error is 20%) detects a difference which is 1.5 SD (standard deviation of different scores). We set 7 and 28 as lower and upper bound of the sample size and randomly assigned mice into each group of the experimental design with the sample size equal to the lower bound. The first test was conducted with seven mice per group. After, the data were collected, the hypothesis test such as t-test was conducted and a p value was obtained. If the p value was less than 0.5, we increased the number (n) of mice to each group by random sampling and this addition would not exceed the upper bound. We used random number generator in Excel (computer-based randomization) to randomly assign mice to each experimental group.
Subchronic MPTP administration without GxTx intervention
The mice (aged 8-12 weeks, 8-10 per group) received intraperitoneal injections of a vehicle or 30 mg/kg of MPTP once daily for five consecutive days. The lethality assessment was less than 10%. Seven days after the last injection, all mice were subjected to behavioral tests and were then sacrificed with over-anesthesia of isoflurane.
Subchronic MPTP administration with GxTx intervention
A dose of 30 mg/kg of MPTP was administered to the mice once a day for 5 days. On day 6, the mice were injected with 0.11 mg/kg of GxTx for seven consecutive days. The lethality assessment was less than 10%. Seven days after the last injection, all mice were subjected to behavioral tests and were then sacrificed with overanesthesia of isoflurane.
Cell culture and surface biotinylation of Kv2.1
The mouse dopaminergic neuroblastoma (MN9D; RRID: CVCL_M067) cell lines developed in the laboratory of Alfred Heller at the University of Chicago were grown in complete medium (Dulbecco's modified Eagle's medium/F-12; Cat #: DFP29-10LT; Caisson Laboratories, Logan, UT, USA), 10% heat-inactivated fetal bovine serum (Cat#: 16000044; Gibco, Rockville, MD, USA), and 1% Penicillin-Streptomycin (Cat #: PSL01-100 mL; Caisson Laboratories). MN9D cells were differentiated in 35-mm culture dishes at a density of 1 9 10 4 in complete medium plus 1 mM n-butyric acid (Cat #:B2503; Sigma, St Louis, MO, USA) for 1 week before drug treatments. To address surface expression of Kv2.1, MN9D cells were subjected to surface biotinylation. Please see the details in the publication (Wu et al. 2015) .
Western blot
The STR and SN of the mice were lysed in 0.1% sodium dodecyl sulfate at 4°C and boiled for 5 min at 95°C. Cell lysates were cleared through centrifugation at 15 000 RCF for 10 min at 4°C. Small aliquots of the lysates were used for protein determination by using the Lowry method (Pierce, Rockford, IL, USA) with bovine serum albumin as the standard. Proteins were separated through sodium dodecyl sulfate-polyacrylamide gel (7.5%-12.5%) electrophoresis and transferred onto polyvinylidene fluoride membranes (EMD Millipore). The membranes were incubated overnight at 4°C with a primary antibody diluted in Tris-buffered saline plus 0.1% Tween-20 (TBST). After three 10-min washes with TBST buffer, the blots were incubated for 1 h at 25°C with horseradish peroxidase-conjugated secondary antibodies in TBST buffer: 1 : 40 000 goat anti-rabbit IgG (GE Healthcare) for SUR1 (1 : 500) and for phospho-AMPK at Thr172 (1 : 1000) and 1 : 2000 horse anti-mouse IgG (GE Healthcare) for Kv2.1 (1 : 500). Finally, the blots were washed three times for 10 min with TBST and were developed using the enhanced chemiluminescence detection kit (Super Signal West Femto; Pierce) . The signals were imaged using a luminescence imaging system (model: M2-8068; Hansor, Taichung, Taiwan). The blots were stripped and re-probed with b-actin as a loading control. Finally, the blots were quantified using ImageJ (NIH, Bethesda, MA, USA) and normalized to the corresponding controls.
Immunofluorescence staining
Frozen sections or MN9D cells after 4% paraformaldehyde (PFA) fixation were rehydrated with phosphate-buffered saline (PBS) and then incubated in PBS containing 3% bovine serum albumin (blocking buffer) for 1 h at 25°C. The primary antibody was diluted to the desired concentration by using the blocking buffer. A primary antibody solution (500 lL; the diluted factor for Kv2.1 was 1-500 and for TH was 1-750) was added into each well, and the plate was incubated at 4°C overnight. According to the experimental designs, Alexa Fluor-conjugated 488 (the diluted factor was 1-750) and 555 (the diluted factor was 1-500) secondary antibodies were added into each well, and the plate was incubated for 1 h at 25°C. Nuclei were counterstained with 10 lg/mL of Hoechst 33342 (Sigma) for 10 min at 25°C. All imaging experiments were performed using a Nikon Digital Eclipse C1si 3-channel confocal microscope (Minatoku, Tokyo, Japan).
Immunohistochemistry
The mice were perfused with PBS first and then 4% PFA. Next, their skulls were opened, and their brains were removed and placed into corresponding 15-mL conical tubes containing 4% PFA solution overnight. On the following day, the brain was transferred into 30% sucrose solution and stored at 4°C for 2 days. The brain was sectioned to a size of 20 lm by using a cryostat, and each section was transferred to a 6-well plate filled with the cryoprotectant and stored at À20°C. Before staining with the Mouse/Rabbit Probe horseradish peroxidase Label Kit (BIOTnA Biotech, Taipei, Taiwan), the sections were washed with PBS twice and then the endogenous peroxidase was eliminated through treatment with hydrogen peroxide for 10 min. After 10 min, the sections were washed with PBS twice following the application of an immunoblocking solution for 30 min at 25°C to block non-specific background staining. The primary TH antibody was diluted to the concentration (the diluted factor was 1-1000) in the blocking buffer. Free-floating brain sections were incubated in 500 lL of the primary antibody solution at 4°C overnight. On the following day, antiRabbit Probe horseradish peroxidase (the diluted factor was 1-2000) was added into each well, and the plate was incubated for 30 min at 25°C after transferring the brain sections out of the primary antibody solution. The sections were washed with PBS three times, followed by the addition of 3,3 0 -diaminobenzidine substrate buffer (30 lL of DAB chromogen in 1 mL of buffer [approximately 1/33 dilution]), and the DAB reaction was monitored for 2-10 min. As shown in the figures presented here, the brain sections were placed in the DAB solution for 3 min. The reaction was terminated, and the brain sections were washed and mounted on clean slides and coverslipped. All the images were captured using a Zeiss photomicroscope (Oberkochen, Germany) and analyzed using ImageJ software (NIH, Bethesda, MA, USA).
Rotarod test
A rotarod machine with automatic timers and falling sensors (Model number 47650; UGO Basile, Gemonio, Italy) was used. The mice were placed on a cylinder with a diameter of 9 cm. Before commencement of the training sessions, the mice were habituated to stay on the stationary cylinder for 1 min. At the beginning of the training session, the rotation was set at a slow speed (4 rpm on the surface) to make the task easier for each mouse; the mice were placed on the drum immediately after they fell, up to five times in one session. A fall was overlooked when the mouse remained on the drum for 180 s. Each mouse received one session per day for 2 days before the test session. During the test session, each mouse was placed on the rod, and the speed of the rod was accelerated from 4 to 40 rpm. The latency to falling for each mouse was recorded.
Open-field test
The locomotor activity was evaluated by placing and allowing a mouse to explore for 30 min in the clear acrylic (40 9 40 9 30 cm) open-field chamber. After 30 min, we began to record the locomotion of each mouse for 120 min and analyzed the traveling distances using ANY-maze Video tracking software 5.1 (Stoelting, Wood Dale, IL, USA).
Image analysis
All fluorescent images were analyzed using NIS-Elements-Basic software version 4.50 (Nikon). Before the measurement, each image was calibrated using a distance assigned to different images. We used regions of interest followed by graticule measurement.
Statistical analysis
All data were analyzed using the program GraphPad Prism 6 (GraphPad Software Inc., San Diego, CA, USA). GraphPad Software Inc., San Diego, CA, USA. Results are expressed as the mean AE SEM. Differences were tested using either one-way or twoway analysis of variance (ANOVA) followed by post hoc Dunnett's test for multiple comparisons. When only two groups were compared, unpaired Student's t-test was used. The level of statistical significance was set at p < 0.05. No blinding was performed in this study and this study was not pre-registered.
Results
Increased Kv2.1 channel expression and diffusion in the STR and SN of subchronic MPTP-treated mice A detailed timeline of this subchronic MPTP mice model is displayed in Fig. 1 (a). To determine whether the expression of the Kv2.1 channel increases during nigrostriatal degeneration, we established the subchronic MPTP mouse model to detect the protein expression of the Kv2.1 channel in the STR and SN on day 12 according to a previous publication ). Damage to midbrain DA neurons caused a loss of tyrosine hydroxylase (TH)-positive terminals in the STR and neurons in the SN (Lees 2009 (Misonou et al. 2008; Mulholland et al. 2008) . Next, we investigated the distribution and expression of Kv2.1 channels through the co-immunofluorescence staining of TH and the Kv2.1 channel in the STR and SN. Sections were stained, as described in Methods, with the anti-TH antibody, followed by Alexa 488-conjugated anti-goat IgG and the anti-Kv2.1 antibody, followed by Alexa 555-conjugated anti-mouse IgG. Striatal sections in the MPTPinjected mice exhibited significantly higher fluorescence for Kv2.1 and lower fluorescence for TH protein than did the PBS-injected mice ( Fig. 2b top and the cropped images) and their fluorescent intensities were quantified, supporting the imaging observation (Fig. 2b bottom) . DA terminals innervate at striatal medium spiny neurons (MSNs), which explained the staining pattern for TH protein in the regions outside medium spiny neurons. In addition, red puncta (expression of Kv2.1 channels) were mostly increased in the plasma membrane of MSNs. Then, we quantified the percentage of co-localization for TH protein and Kv2.1 channels. By contrast, the co-localization of Kv2.1 at THpositive terminals was significantly higher in the MPTPinjected mice than in the control mice (Fig 2b, bottom right) .
The results of confocal microscopy examination of the expression of Kv2.1 channels and TH protein in the SN DA neurons were similar to those of STR DA terminals (Fig. 3b , top and the cropped images), and the quantification of their fluorescence intensities and the percentage of co-localization supported the imaging observation (Fig. 3b, bottom) . Taken together, subchronic MPTP treatment significantly reduced TH-positive terminals in the STR and cell bodies in the SN with concomitant increase in the expression of Kv2.1 channels. Next, we examined the necessity of the MPTPup-regulated insertion of Kv2.1 for nigrostriatal degeneration.
Inhibition of the Kv2.1 channel rescued MPTP-induced nigrostriatal degeneration in the SN and STR A detailed timeline for post-injection of GxTx in MPTPinjected mice is shown in Fig. 1 
(b). The tarantula peptide
GxTx is a potent inhibitor of Kv2.1 activity through direct binding (Liu and Bean 2014) . To investigate whether the inhibition of Kv2.1 activity rescues MPTP-induced nigrostriatal degeneration, the mice were treated with MPTP for 5 days and then with 0.11 mg/kg of GxTx for 7 days (MPTP/ GxTx). We performed immunohistochemistry by staining STR and SN sections with the TH antibody on day 19. As expected, MPTP caused the degeneration of TH-positive DA terminals in the STR and loss of TH-positive DA neurons in the SN. The MPTP/GxTx-treated mice exhibited intense THpositive staining both in the STR and SN than did the MPTPtreated mice (Fig. 4a, top) . The MPTP-injected mice develop poor motor control (Mann et al. 1994; Przedborski et al. 2004) . Hence, we used the rotarod and open field, common behavioral tests to evaluate motor coordination. The results revealed that the MPTP/GxTx-treated mice exhibited performance similar to that of the control mice and significantly more efficient motor control than did the MPTP-injected mice ( Fig. 4b top and bottom) . The expression of Kv2.1 channels and TH protein in the SN and STR of the MPTP/GxTx mice was also further supported by a decrease in Kv2.1 channels and an increase in TH protein ( Fig. 4c and d) . In summary, increased expression of Kv2.1 is necessary for MPTP to induce nigrostriatal degeneration.
GxTx-mediated protection was induced through decreasing surface expression of Kv2.1 rather than GIRK1 We examined whether GxTx affects the abundance of the Kv2.1 channel at the cell surface and DA terminals after MPTP injection. An increase in the surface expression of Kv2.1 channels was observed in the MPTP-injected mice. In addition, the MPTP/GxTx mice exhibited lower surface expression of Kv2.1 channels and higher expression of DA terminals (Fig. 5a ). Quantification for fluorescent intensity of surface Kv2.1 and the number of TH-immunopositive terminals among these four groups of mice supported the imaging observation and importantly strengthened GxTx-mediated protection (Fig. 5a right) . Many DA Fig. 1 The timeline diagram for animal studies. (a) Eight weeks old B6 mice were injected either with phosphate-buffered saline (PBS) or 30 mg/kg of MPTP intraperitoneally for 5 days. They were both drug free for 7 days. On day 12, these mice were subjected to experiments as specified in the Materials and Methods.
(b) Eight weeks old B6 mice were injected either with PBS or 30 mg/kg of MPTP intraperitoneally for 5 days followed by 0.11 mg/kg of guangxitoxin 1E (GxTx) for seven consecutive days. On day 19, all mice were subjected to experiments as specified in the Materials And Methods.
terminals were observed in the STR of the MPTP/GxTx mice, indicating that these mice had more efficient motor coordination (Fig. 4b) . To assess whether the effect of MPTP was specific to Kv2.1 channels, we examined the surface expression of another membrane protein, GIRK1, by using the same brain samples. GIRK1 is unlikely to form functional homomeric tetramers and may require GIRK2 to form functional channels. Heteromeric GIRK1/2 channels and homomeric GIRK2 channels are expressed in the STR and SN. Most importantly, GIRK1/GIRK2 exists as a major component of GIRK channels in the mammalian brain (Liao et al. 1996) . An increase in the expression of GIRK2 channels can be as a result of either more homomeric GIRK2 or heteromeric GIRK1/GIRK2 channels (Mayfield et al. 2015) . In either case, GIRK1 subunits are well suited to be an important protein in the nigrostriatal degeneration. Hence, we decided to probe GIRK1 expression in the STR and SN. No difference in the total expression of GIRK1 was observed between PBS-and MPTP-treated mice in the STR (Fig. 5b  top) and the SN (Fig. 5b bottom) , indicating that MPTP does not alter the global protein expression or membrane trafficking.
Surface expression of the Kv2.1 channel under MPP + administration The MN9D cell line, a fusion of embryonic ventral mesencephalic and neuroblastoma cells, has been used to evaluate mechanisms and potential therapeutics relevant to the loss of DA neurons in PD (Choi et al. 1992; Rick et al. 2006) . In parallel with the in vivo experiments, 5 9 10 6 MN9D cells per well in a 6-well plate were differentiated and treated with 50 lM of MPP + for 48 h in the absence or presence of 0.25 nM of GxTx for 48 h through surface biotinylation and immunostaining to assess protein expression and distribution of TH and Kv2.1. Surface biotinylation experiments demonstrated that MPP + increased the surface expression of Kv2.1, and this increase was further reduced by GxTx (Fig. 6a) . The immunostaining result revealed that MPP + -treated cells clearly displayed Kv2.1 channels in the cell periphery and cytoplasm compared with dimethyl sulfoxide-or GxTx-treated cells. Co-treatment with GxTx and MPP + reduced the surface expression of Kv2.1 channels (Fig. 6b) . We also performed whole cell recording to measure Kv2.1 currents after subtracting GxTx-insensitive potassium currents. In the control cell, Kv2.1-specific potassium currents was identified by recording MN9D cells in the presence of 0.25 nM GxTx ( Figure S1a ) and the amplitude of Kv2.1 was increased in the voltage-dependent manner ( Figure S1b) . We presented Kv2.1-specific currents against each voltage in the MPP + -treated cell with or without co-treating GxTx-1E for 30 min ( Figure S1c and d) . In addition, we stained differentiated MN9D cells with TH and Kv2.1 antibodies after the experiments. As shown in the Figure S1 (e), the MPP + -treated MN9D cells decreased THcontaining neurites (in green fluorescence) and increased surface staining Kv2.1 (in red fluorescence) than the control cells. In the combinations of surface biotinylation, immunofluorescence staining, and whole cell recording, we showed that MPP + increased surface expression of Kv2.1 and this increase was further inhibited by GxTx in THpositive dopaminergic cell line (MN9D). Next, we examined whether this effect of GxTx on the reduction in expression of Kv2.1 channels during MPP + treatment was because of the modulation of channel pore openings. TEA is a particularly well-studied compound that binds relatively strongly to K + channels near the extracellular and intracellular entries of the K + channel pore (del Camino et al. 2000; Consiglio and Korn 2004) . The differentiated MN9D cells received a similar treatment, but we used 10 mM of TEA to replace GxTx, which is known to inhibit the Kv2.1 channel activity (Wu et al. 2015) . In the absence of TEA, the MPP + -treated cells yielded lower expression of TH and higher expression of Kv2.1 compared with the control cells. However, TEA did not reduce the expression of the Kv2.1 channel or recover the TH-positive DA terminals upon MPP + treatment (Fig. 6c) . Taken together, GxTx did not affect the expression of Kv2.1 channels. MPP + treatment increased the total Kv2.1 expression, particularly on the surface. Notably, this effect can be occluded by GxTx, suggesting that the mechanism by which GxTx reduced the MPP + -induced up-regulation of Kv2.1 channels is not gating. showed the quantitative data for GIRK1 signals that were normalized to the b-actin signal (Data were presented as the mean AE SEM; n = 8 per group; N.S. indicates no significant difference from the PBS-treated group by using the unpaired t-test).
protected the differentiated MN9D cells against MPP + toxicity (Fig. 7a) . To probe the underlying mechanism of GxTx-mediated protection, we compared the protein expression of TH, pAMPK, and cleaved caspase 3. Immunoblotting results revealed that chronic MPP + treatment down-regulated the level of TH protein and up-regulated the levels of Kv2.1, AMPK phosphorylation at threonine 172, and cleaved caspase 3. Notably, GxTx reversed the effects of MPP + toxicity (Fig. 7b) .
The density of a membrane protein at the cell surface is a balance between its delivery to and removal from the plasma membrane. The recruitment of vesicles to endocytosed oxidized Kv2.1 channels has been reported to reduce channel activity (Masumiya et al. 2009 ). Considering that the inhibition of the surface expression of Kv2.1 channels by GxTx appears to be a key protective effect against MPTP/ MPP + -induced toxicity, we examined Kv2.1 channels and early endosomes through EEA1 (the marker for endosome) antibody-based imaging. Differentiated MN9D cells transiently transfected with a Kv2.1 variant with a fluorescent protein mCherry fused to the channel were treated with a vehicle or 50 lM of MPP + for 30 min in the absence or presence of 0.25 nM of GxTx. Kv2.1 channels were increased in the cytoplasm and cell periphery but not colocalized with EEA1-positive vesicles. In GxTx-and MPP + -treated cells, more EEA1-positive endosomes and less Bar graphs showed quantitative data for the Kv2.1 channel and TH protein signals that were normalized to the b-actin signal (Data were presented as the mean AE SEM; n = 6 per group, N.S. or *p < 0.05 compared with the DMSO-treated group; + p < 0.05 compared with the MPP + -treated group; N.S. indicates no significant difference from the phosphate-buffered saline (PBS)-treated group by using the unpaired t-test; differences were evaluated using one-way ANOVA and Dunnett's post hoc test).
expression of Kv2.1 channels were observed. In addition, more co-localization of Kv2.1 and EEA1 was observed in this group (Fig. 8a) . Regarding forward trafficking, a previous report indicated that elevated AMPK activity contributes to Kv2.1 channel trafficking to the plasma membrane in pancreatic b cells (Wu et al. 2015) . As shown in Fig. 8(b) , we treated MN9D cells with either 50 lM of MPP + or 250 lM of 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR, AMPK activator) for 30 min in the absence or presence of the AMPK inhibitor compound C (10 lM). AICAR mimicked the MPP + effects of an increase in the expression of Kv2.1 channels, and this increase was blocked by the AMPK inhibitor compound C. In conclusion, MPTP/ MPP + might act on forward and reverse trafficking to increase the expression of Kv2.1 channels. Kv2.1 channels participate in MPP + -induced cell apoptosis in GxTx rescued cells by reducing the expression of Kv2.1 channels through either reducing AMPK phosphorylation or recruiting endosomes (Fig 9) .
Discussion
In this study, we demonstrated that MPTP/MPP + increased the surface expression of Kv2.1 channels. This increased expression of Kv2.1 induced by chronic MPTP exposure results in nigrostriatal DA neuron degeneration, leading to involuntary motor coordination in mice and MPP + -induced death of differentiated dopaminergic cells. The reduced Representative western blots showed TH, pAMPK, and cleaved caspase 3 proteins in the MN9D cells. Bar graphs showed the quantification of TH, pAMPK, and cleaved caspase 3 that were normalized to the bactin signal (Data were presented as the mean AE SEM; n = 6 per group; *p < 0.05 compared with the PBS group; +p < 0.05 compared with the MPP + group; differences were evaluated using one-way ANOVA and Dunnett's post hoc test).
expression of Kv2.1 by GxTx improved motor coordination in mice and rescued DA degeneration in the subchronic MPTP-induced Parkinsonism mouse model and MPP + -induced cell apoptosis. Kv2.1 channel trafficking is necessary for nigrostriatal DA neuron degeneration. Furthermore, the underlying mechanism revealed that AMPK phosphorylation is necessary to increase the expression of Kv2.1 channels; in addition, acute GxTx inhibition on Kv2.1 channel trafficking correlated with the level of endosomes in vitro in the acute MPP + treatment model. This serendipitous finding was observed when we tested GIRK1 potassium channels and the other Kv2.1 channel inhibitor TEA as the potential control to demonstrate that the effect of MPTP/ MPP + on Kv2.1 channels was specific and that the inhibition of Kv2.1 channel expression was the key to rescuing DA neuron degeneration.
AMPK phosphorylation regulates the expression and function of ion channels (Evans et al. 2012; Lang et al. 2012; Chen et al. 2013; Wu et al. 2015) . The Kv2.1 channel possesses variable phosphorylation sites at its C terminus including the AMP-activated protein kinase AMPK (Minokoshi et al. 2002; Anderson et al. 2008) . AMPK phosphorylates the Kv2.1 channel at Ser440 and Ser537 to regulate membrane excitability, and an increase in AMPK phosphorylation at Thr172 promotes the membrane insertion of the Kv2.1 channel (Ikematsu et al. 2011; Wu et al. 2015) . AICAR mimicked the MPP + -increased Kv2.1 expression, and compound C occluded the effects of MPP + and AICAR. Notably, compound C also inhibited MPP + -induced Kv2.1 expression, which implicates that MPP + might activate AMPK to increase the expression of Kv2.1 channels. However, whether these sites are involved in mediating the effect of MPP + requires further investigation. Neurons respond to rapidly changing signals in their synaptic transmission. Without homeostatic plasticity, neurons alter their frequencies or durations of each spike at near maximal or minimal firing (Surmeier and Foehring 2004) . MPTP/MPP + -increased Kv2.1 channel expression exposes neuronal networks to the risk of explosion or crashes. In addition to regulating cell excitability, the enhanced efflux of K + leads to apoptotic cell shrinkage before DNA fragmentation, cytochrome c release, and caspase 3 activation (Burg et al. 2006; Pal et al. 2006) . Moreover, the plasma membrane Kv2.1 clusters on the somata and proximal dendrites of pyramidal neurons lie over intracellular endoplasmic reticulum-derived membranes rich in inositol triphosphate and ryanodine receptors (Du et al. 2000) . Percentage of 90-95 of striatal MSNs use c-aminobutyric acid as a neurotransmitter and express either DA D1-like receptor (D1-MSNs) or D2-like receptor (D2-MSNs) (Graveland and DiFiglia 1985; Aizman et al. 2000) . It has already been studied that loss of DA input induces spine pruning which appears to be a signature for synaptic plasticity since the reduction of spine density observed on the MSNs (Zaja-Milatovic et al. 2005; Villalba et al. 2009; Gagnon et al. 2017) . We found that the MPTP/MPP + -increased expression of Kv2.1 channels mostly occurred in the plasma membrane of MSNs in the STR in addition to TH-containing DAnergic axons. The surface Kv2.1 channels might come into close apposition with intracellular Ca 2+ stores, representing a specialized neuronal signaling domain that may also contain elevated levels of voltage-dependent Ca 2+ channels (Ahlijanian et al. 1990 ). We suspect that MPTP/MPP + -up-regulated surface expression of Kv2.1 in the MSNs initiate the process of synaptic pruning followed by loss of spine densities, leading to synaptic degeneration in MSNs. In addition, there was an increase in Kv2.1 expression in non-DAnergic neurons in the SN. Of note, the midbrain DAnergic neurons are interspersed with GABAergic neurons and with glutamatergic neurons (Nair-Roberts et al. 2008; Yamaguchi et al. 2013; Morales and Root 2014) . Upon MPTP/MPP + treatment, this increase in Kv2.1 channels might also result in the increase in intracellular Ca 2+ concentration or Ca 2+ influx into the cell, connecting the K + efflux to calcium and calcium signaling underlying neurodegenerative diseases (James Surmeier et al. 2017; Pchitskaya et al. 2017) . There is no doubt that SN DAnergic neurons die because of MPTP/MPP + -upregulated surface expression of Kv2.1 in absence of other cell types. However, when one looks at this complex system in the SN, we speculate that increased expression of Kv2.1 in the surrounding non-DAnergic neurons might exert deleterious effects on the remaining DAnergic neurons. However, this remains to be investigated. Because of potential therapeutic implications, the pharmacology of Kv2.1 in various toxins and drugs has been extensively investigated (Mathie et al. 1998; Ye et al. 2009; Herrington et al. 2011) . GxTx inhibits the Kv2.1 channel by interacting with the voltage sensor (Lee et al. 2010; Chen et al. 2012) . In our study, GxTx reduced the expression of Kv2.1 channels both in vivo and in vitro experiments. In acute MPP + -treated MN9D cells, GxTx also inhibited the expression of Kv2.1 channels. Our data suggest that GxTx has dual functions of Kv2.1 channel inhibition by altering ion channel's gating and surface expression. The anti-arrhythmic drug quinidine, which is a pore blocker for Kv1.5, induces the endocytosis of Kv1.5 (Ishii et al. 2012) . The number of ion channels in the plasma membrane is determined by channel insertion, channel endocytosis, and the recycling of the endocytosed channel back to the membrane (Curran and Mohler 2015; Ohya et al. 2016) . AMPK phosphorylation regulates the expression and function of ion channels (Evans et al. 2012; Lang et al. 2012; Chen et al. 2013; Wu et al. 2015) . The correlations between reduced AMPK phosphorylation by GxTx in chronic MPP + -treated MN9D cells and increased levels of endosomes might be the underlying mechanism by which GxTx reduced the MPTP/MPP + -increased expression of the Kv2.1 channel and rescued cell death.
In summary, our study revealed that MPTP/MPP + -induced surface expression of the Kv2.1 channel is necessary for nigrostriatal degeneration. We are unaware of any epidemiological studies that report an association between Kv2.1 and patients with PD; however, such studies are warranted. Considering the effect of PD on global human health concerns, these findings suggest that the Kv2.1 channel can be a potential pharmacological candidate for PD treatment.
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